During the past decade, ICU, Beijing Tiantan Hospital, Capital Medical University conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "ICU, Beijing Tiantan Hospital, Capital Medical University" #1 sponsor was "Capital Medical University" with 12 trials, followed by "Beijing Tiantan Hospital" with 5 trials sponsored, "Cure&Sure Biotech Co., LTD" with 1 trials sponsored, "Li Peng" with 1 trials sponsored and "Peking University Third Hospital" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "ICU, Beijing Tiantan Hospital, Capital Medical University" #1 collaborator was "Peking University International Hospital" with 3 trials as a collaborator, "Binzhou Medical University" with 2 trials as a collaborator, "First Affiliated Hospital of Fujian Medical University" with 2 trials as a collaborator, "First Affiliated Hospital of Harbin Medical University" with 2 trials as a collaborator and "Qilu Hospital of Shandong University" with 2 trials as a collaborator. Other collaborators include 43 different institutions and companies that were collaborators in the rest 52 trials.

According to Clinical.Site data, the most researched conditions in "ICU, Beijing Tiantan Hospital, Capital Medical University" are "Mechanical Ventilation" (5 trials), "Neurosurgery" (2 trials), "Acute Brain Injury" (1 trials), "Acute Ischemic Stroke" (1 trials) and "Aneurysmal Subarachnoid Hemorrhage" (1 trials). Many other conditions were trialed in "ICU, Beijing Tiantan Hospital, Capital Medical University" in a lesser frequency.

Most popular intervention types in "ICU, Beijing Tiantan Hospital, Capital Medical University" are "Drug" (8 trials), "Procedure" (4 trials), "Biological" (1 trials), "Device" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Antiplatelet Agents" (1 trials), "Dexmedetomidine" (1 trials), "Esophagus balloon catheter insertion." (1 trials), "Fentanyl" (1 trials) and "Icotinib" (1 trials). Other intervention names were less common.

The vast majority of trials in "ICU, Beijing Tiantan Hospital, Capital Medical University" are 22 trials for "All" genders.

Currently, there are NaN active trials in "ICU, Beijing Tiantan Hospital, Capital Medical University". undefined are not yet recruiting, 6 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in ICU, Beijing Tiantan Hospital, Capital Medical University, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in ICU, Beijing Tiantan Hospital, Capital Medical University, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 5 trials that are defined as “Not Applicable".